Global Induced Pluripotent Stem Cells (iPSc) Market Market Research Report 2021(Status and Outlook)
Report Overview:
Induced pluripotent stem cells are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery.
Bosson Research’s latest report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from macro overview of the market to micro details of the market size, competitive landscape ,development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Induced Pluripotent Stem Cells (iPSc) Market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.
Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis:
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
By Company | Type Segmentation |
l Lonza l Axol Bioscience Ltd. l Evotec l Hitachi Ltd. l Merck KGaA l REPROCELL Inc. l Fate Therapeutics l Thermo Fisher Scientific, Inc. l StemCellFactory III l Applied StemCell Inc. l Fujifilm Holding Corporation (CDI) l Ncardia l Sumitomo Dainippon harma l Astellas Pharma Inc l Pluricell Biotech l Cell Inspire Biotechnology | l Hepatocytes l Fibroblasts l Keratinocytes l Amniotic Cells |
Application Segmentation | |
l Academic Research l Drug Development and Discovery l Toxicity Screening l Regenerative Medicine l Others | |
Overview of the Regional Outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Geographic Segmentation (M USD) | 2017 | 2021 | 2028 | Share (2021) | CAGR (2021-2028) | |
North America | USA | XX | XX | XX | XX% | XX% |
Canada | XX | XX | XX | XX% | XX% | |
Mexico | XX | XX | XX | XX% | XX% | |
Europe | Germany | XX | XX | XX | XX% | XX% |
UK | XX | XX | XX | XX% | XX% | |
France | XX | XX | XX | XX% | XX% | |
Russia | XX | XX | XX | XX% | XX% | |
Italy | XX | XX | XX | XX% | XX% | |
Rest of Europe | XX | XX | XX | XX% | XX% | |
Asia-Pacific | China | XX | XX | XX | XX% | XX% |
Japan | XX | XX | XX | XX% | XX% | |
South Korea | XX | XX | XX | XX% | XX% | |
India | XX | XX | XX | XX% | XX% | |
Southeast Asia | XX | XX | XX | XX% | XX% | |
Rest of Asia-Pacific | XX | XX | XX | XX% | XX% | |
South America | Brazil | XX | XX | XX | XX% | XX% |
Argentina | XX | XX | XX | XX% | XX% | |
Columbia | XX | XX | XX | XX% | XX% | |
Rest of South America | XX | XX | XX | XX% | XX% | |
Middle East and Africa | Saudi Arabia | XX | XX | XX | XX% | XX% |
UAE | XX | XX | XX | XX% | XX% | |
Egypt | XX | XX | XX | XX% | XX% | |
Nigeria | XX | XX | XX | XX% | XX% | |
South Africa | XX | XX | XX | XX% | XX% | |
Rest of MEA | XX | XX | XX | XX% | XX% | |
Global | XX | XX | XX | XX | XX% |
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market
• Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Key Reasons to Buy this Report:
• Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change
• This enables you to anticipate market changes in order to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents
• The concise analysis, clear graph and table format will enable you to pin point the information your require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.
Table of Contents
1 Induced Pluripotent Stem Cells (iPSc) Market Competitive Landscape
1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2017-2022)
1.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2017-2022)
1.3 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
1.4 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2017-2022)
1.5 Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites, Area Served, Product Type
1.6 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends
1.6.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate
1.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue
1.6.3 Mergers & Acquisitions, Expansion
2 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
2.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
2.2 Market Overview and Market Concentration Analysis of Key Raw Materials
2.4 Downstream Customer Analysis
3 The Development and Dynamics of Induced Pluripotent Stem Cells (iPSc) Market
3.5.1 New Product Developments
4 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Type
4.1 Evaluation Matrix of Segment Market Development Potential (Type)
4.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)
4.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2017-2022)
4.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2017-2022)
5 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Application
5.1 Evaluation Matrix of Segment Market Development Potential (Application)
5.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2017-2022)
5.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2017-2022)
5.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)
6 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Region
6.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
6.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
6.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region
6.2.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country
6.3.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country
6.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region
6.5.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country
6.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region
7.1.1 Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information
7.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
7.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.1.5 Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
7.1.6 Lonza Recent Developments
7.2.1 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
7.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
7.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.2.4 Axol Bioscience Ltd. Business Overview
7.2.5 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
7.2.6 Axol Bioscience Ltd. Recent Developments
7.3.1 Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information
7.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
7.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.3.4 Evotec Business Overview
7.3.5 Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
7.3.6 Evotec Recent Developments
7.4.1 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
7.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
7.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.4.4 Hitachi Ltd. Business Overview
7.4.5 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
7.5.1 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information
7.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
7.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.5.4 Merck KGaA Business Overview
7.5.5 Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
7.5.6 Merck KGaA Recent Developments
7.6.1 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
7.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
7.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.6.4 REPROCELL Inc. Business Overview
7.6.5 REPROCELL Inc. Recent Developments
7.7.1 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information
7.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
7.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.7.4 Fate Therapeutics Business Overview
7.7.5 Fate Therapeutics Recent Developments
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
7.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
7.8.4 Thermo Fisher Scientific, Inc. Business Overview
7.8.5 Thermo Fisher Scientific, Inc. Recent Developments
7.9.1 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information
7.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
7.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.9.4 StemCellFactory III Business Overview
7.9.5 StemCellFactory III Recent Developments
7.10.1 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
7.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
7.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.10.4 Applied StemCell Inc. Business Overview
7.10.5 Applied StemCell Inc. Recent Developments
7.11 Fujifilm Holding Corporation (CDI)
7.11.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information
7.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
7.11.4 Fujifilm Holding Corporation (CDI) Business Overview
7.11.5 Fujifilm Holding Corporation (CDI) Recent Developments
7.12.1 Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information
7.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
7.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.12.4 Ncardia Business Overview
7.12.5 Ncardia Recent Developments
7.13.1 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information
7.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
7.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.13.4 Sumitomo Dainippon harma Business Overview
7.13.5 Sumitomo Dainippon harma Recent Developments
7.14.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information
7.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
7.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.14.4 Astellas Pharma Inc Business Overview
7.14.5 Astellas Pharma Inc Recent Developments
7.15.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information
7.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
7.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.15.4 Pluricell Biotech Business Overview
7.15.5 Pluricell Biotech Recent Developments
7.16 Cell Inspire Biotechnology
7.16.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information
7.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
7.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance
7.16.4 Cell Inspire Biotechnology Business Overview
7.16.5 Cell Inspire Biotechnology Recent Developments
8 Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
8.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast
8.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
8.2.1 North America Market Size Forecast by Country
8.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
8.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region
8.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
9 Forecast Market by Type and by Application (2022-2028)
9.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2022-2028)
9.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)
9.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028)
9.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)
9.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2022-2028)
9.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application
10 Conclusion and Key Findings
List of Tables
Table 1. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Manufacturers (2017-2022)
Table 3. Global Induced Pluripotent Stem Cells (iPSc) Revenue (M USD) by Manufacturers (2017-2022)
Table 4. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers (2017-2022)
Table 7. Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites and Area Served
Table 8. Manufacturers Induced Pluripotent Stem Cells (iPSc) Product Type
Table 10. Mergers & Acquisitions, Expansion Plans
Table 11. Industry Chain Map of Induced Pluripotent Stem Cells (iPSc)
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 17. Induced Pluripotent Stem Cells (iPSc) Market Challenges
Table 19. Global Induced Pluripotent Stem Cells (iPSc) Sales by Type (K Units)
Table 20. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Type (M USD)
Table 21. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Type (2017-2022)
Table 22. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)
Table 23. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Type (2017-2022)
Table 24. Global Induced Pluripotent Stem Cells (iPSc) Market Size Share by Type (2017-2022)
Table 25. Global Induced Pluripotent Stem Cells (iPSc) Price (USD/Unit) by Type (2017-2022)
Table 26. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Application
Table 27. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application
Table 28. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (K Units)
Table 29. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2017-2022)
Table 30. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (M USD)
Table 31. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022)
Table 32. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)
Table 33. Global Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units)
Table 34. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022)
Table 36. Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units)
Table 37. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units)
Table 40. Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 41. Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 43. Lonza Business Overview
Table 44. Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
Table 45. Lonza Recent Developments
Table 46. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 47. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 49. Axol Bioscience Ltd. Business Overview
Table 50. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
Table 51. Axol Bioscience Ltd. Recent Developments
Table 52. Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 53. Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 55. Evotec Business Overview
Table 56. Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
Table 57. Evotec Recent Developments
Table 58. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 59. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 61. Hitachi Ltd. Business Overview
Table 62. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
Table 63. Hitachi Ltd. Recent Developments
Table 64. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 65. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis
Table 69. Merck KGaA Recent Developments
Table 70. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 71. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 73. REPROCELL Inc. Business Overview
Table 74. REPROCELL Inc. Recent Developments
Table 75. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 76. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 78. Fate Therapeutics Business Overview
Table 79. Fate Therapeutics Recent Developments
Table 80. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 81. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 83. Thermo Fisher Scientific, Inc. Business Overview
Table 84. Thermo Fisher Scientific, Inc. Recent Developments
Table 85. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 86. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 88. StemCellFactory III Business Overview
Table 89. StemCellFactory III Recent Developments
Table 90. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 91. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 93. Applied StemCell Inc. Business Overview
Table 94. Applied StemCell Inc. Recent Developments
Table 95. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 96. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 98. Fujifilm Holding Corporation (CDI) Business Overview
Table 99. Fujifilm Holding Corporation (CDI) Recent Developments
Table 100. Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 101. Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 103. Ncardia Business Overview
Table 104. Ncardia Recent Developments
Table 105. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 106. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 108. Sumitomo Dainippon harma Business Overview
Table 109. Sumitomo Dainippon harma Recent Developments
Table 110. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 111. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 115. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 116. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 118. Pluricell Biotech Business Overview
Table 119. Pluricell Biotech Recent Developments
Table 120. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information
Table 121. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 123. Cell Inspire Biotechnology Business Overview
Table 124. Cell Inspire Biotechnology Recent Developments
Table 125. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (K Units)
Table 126. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (M USD)
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSc) Sales Share by Manufacturers in 2020
Figure 2. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers in 2020
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Type
Figure 8. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022)
Figure 9. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020
Figure 10. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022)
Figure 11. Market Size Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020
Figure 12. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application
Figure 14. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application in 2020
Figure 15. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022)
Figure 16. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application in 2020
Figure 17. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)
Figure 18. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022)
Figure 20. North America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020
Figure 21. U.S. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 22. Canada Induced Pluripotent Stem Cells (iPSc) Sales (K Units) and Growth Rate (2017-2022)
Figure 23. Mexico Induced Pluripotent Stem Cells (iPSc) Sales (Units) and Growth Rate (2017-2022)
Figure 25. Europe Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020
Figure 28. U.K. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 29. Italy Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units)
Figure 32. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2020
Figure 33. China Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 34. Japan Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. India Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. South America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units)
Figure 39. South America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020
Figure 46. UAE Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. Egypt Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Type (2022-2028)
Figure 54. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Application (2022-2028)